HEMATOLOGIC CANCER

Clinical trials for HEMATOLOGIC CANCER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC CANCER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1

First patients test new oral drug for Tough-to-Treat blood cancers

Disease control Ongoing

This is the first human study of an experimental oral drug called ABBV-101 for people with advanced B-cell blood cancers that have returned or not responded to previous treatments. The main goals are to find a safe dose and see how the body processes the drug, while also checking…

Matched conditions: HEMATOLOGIC CANCER

Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control

Last updated Apr 01, 2026 22:56 UTC

HEMATOLOGIC CANCER

Get alerted when new HEMATOLOGIC CANCER trials appear

First patients test new oral drug for Tough-to-Treat blood cancers